| 1. | | Recruiting | Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer
Condition: Breast Cancer |
| 2. | | Completed | A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
Conditions: Candidiasis, Oral; HIV Infections |
| 3. | | Recruiting | EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-segment Elevation Acute Coronary Syndrome
Condition: Myocardial Ischemia |
| 4. | | Completed | Farnesyl Protein Transferase Inhibitor (FPTI) in Combination with Docetaxel in Advanced Solid Tumors
Condition: Neoplasms |
| 5. | | Recruiting | Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
Condition: Mycoses |
| 6. | | Completed | Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
Condition: Mycoses |
| 7. | | Completed | Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
Conditions: ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ... |
| 8. | | Recruiting | Peg-Ifn Dose Evaluations for Previously Untreated Subjects with Chronic Hepatitis C Infected with Genotype 1
Condition: Chronic Hepatitis C |
| 9. | | Terminated | PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron
Condition: Leukemia, Myeloid, Philadelphia-Positive |
| 10. | | Recruiting | Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients with Cirrhosis
Conditions: Chronic Hepatitis C; Cirrhosis |
| 11. | | Recruiting | PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to alpha-Interferon Plus Ribavirin
Conditions: Chronic Hepatitis C; Liver Fibrosis; Cirrhosis |
| 12. | | Completed | Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
Conditions: Cytomegalovirus Retinitis; HIV Infections |
| 13. | | Completed | Phase III PEG-Intron in HIV-infected patients
Conditions: HIV Infections; AIDS |
| 14. | | Completed | A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin; HIV Infections |
| 15. | | No longer recruiting | PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections
Condition: Mycoses |
| 16. | | Recruiting | Prevention of Disease Progress in Chronic Hepatitis C Patients with Liver Fibrosis
Conditions: Chronic Hepatitis C; Liver Fibrosis |
| 17. | | Completed | Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients with Graft vs. Host Disease
Condition: Mycoses |
| 18. | | Recruiting | Prophylaxis Trial of Posaconazole vs. Standard Azole Therapy for Neutropenic Patients
Conditions: Leukemia, Myelocytic, Acute; Myelodysplastic Syndromes; Neutropenia |
| 19. | | Completed | The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients with Hepatitis C Plus Advanced HIV Infections
Conditions: HIV Infections; Hepatitis C |
| 20. | | Completed | Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
Conditions: Candidiasis, Oral; HIV Infections |
| 21. | | Completed | The Safety and Effectiveness of Ganciclovir Used Alone or in Combination with Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients with AIDS
Conditions: Cytomegalovirus Retinitis; HIV Infections |
| 22. | | Completed | The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients with Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi; HIV Infections |
| 23. | | Completed | Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
Condition: HIV Infections |
| 24. | | Terminated | Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis
Conditions: Bile Duct Diseases; Biliary Tract Diseases; Gallbladder Diseases; Pancreatitis; Pancreatic Diseases |
| 25. | | Terminated | Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination with Gemcitabine and Cisplatin in Advanced Cancer
Condition: Neoplasms |
| 26. | | Completed | SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
Conditions: Meningitis, Cryptococcal; HIV Infections |
| 27. | | Completed | SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; malignant ascites; peritoneal cavity cancer; Fallopian Tube Cancer |
| 28. | | Terminated | Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients with Leukemia
Conditions: Leukemia; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic; Blast Crisis; Leukemia, Lymphocytic |
| 29. | | Terminated | Study of Lonafarnib in Combination with Paclitaxel and Carboplatin in Patients with Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm |
| 30. | | Completed | Study of Lonafarnib in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Conditions: Carcinoma, Squamous Cell; Head and Neck Neoplasms |
| 31. | | Completed | Study of Temozolomide in the Treatment of Brain Metastasis from Non-small-cell Lung Cancer
Conditions: Metastases, Neoplasm; Carcinoma, Non-Small-Cell Lung; Brain Neoplasms |
| 32. | | Recruiting | Temozolomide for Treatment of Brain Metastases from Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Brain Neoplasms |
| 33. | | Recruiting | Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma
Condition: Melanoma |
